National Hog Farmer is part of the Informa Markets Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Enlisting Bananas in the Fight Against PRRS


With current vaccines of limited value in the fight against porcine reproductive and respiratory syndrome (PRRS), a National Taiwan University (NTU) team took a different tact. They developed transgenic bananas to orally vaccinate swine against PRRS, which they consider a major breakthrough with great economic potential, the Republic of China National Science Council (NSC) said July 17.

The team was led by professor Huang Pung-ling of the NTU Department of Horticulture and Landscape Architecture and professor Jeng Chian-ren, director of the NTU Graduate Institute of Molecular and Comparative Pathobiology. Its research made the front cover of the April issue of the prestigious Plant Biotechnology Journal.

After PRRS first emerged at the end of the 1980s, it caused serious damage to the hog industry in Europe and the United States, and spread to Taiwan in 1991. The disease causes miscarriages, weak newborns and a low litter survival rate, creating serious economic losses, with Taiwan virus strains even more virulent than those found abroad, the NSC said.

NSC said that neither inactivated or attenuated vaccine forms are effective in activating the pig’s immune system.

Moreover, vaccines effective against one strain of the disease have limited efficacy against other strains.

The NTU team used genetic engineering technology to transfer some of the virus’ genetic material to the banana chromosome. The banana effectively functions as a bioreactor, producing a vegetable oral vaccine. As the time-consuming and costly injection process is avoided, the biovaccine has high economic value, the NSC said.

“Pigs can eat the vaccine as raw food,” Huang said. “It is extremely convenient and there is no risk of secondary infection or attenuation of vaccine proteins in the cooking process.” He added that the vaccine would be safe and readily prepared.

“Patents have already been secured in Taiwan, the United States and mainland China. In the future, the technique could be used to produce vaccines for cattle, sheep and poultry diseases, and possibly even against human illnesses such as hepatitis and influenza.”

The research was reported in this week’s Iowa Pork Industry Center online newsletter (





Hide comments


  • Allowed HTML tags: <em> <strong> <blockquote> <br> <p>

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.